MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes.


Journal

Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427

Informations de publication

Date de publication:
22 02 2021
Historique:
received: 04 12 2019
revised: 23 12 2019
accepted: 22 01 2020
pubmed: 17 3 2020
medline: 5 1 2022
entrez: 17 3 2020
Statut: ppublish

Résumé

In long QT syndrome (LQTS) patients, modifier genes modulate the arrhythmic risk associated with a disease-causing mutation. Their recognition can improve risk stratification and clinical management, but their discovery represents a challenge. We tested whether a cellular-driven approach could help to identify new modifier genes and especially their mechanism of action. We generated human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) from two patients carrying the same KCNQ1-Y111C mutation, but presenting opposite clinical phenotypes. We showed that the phenotype of the iPSC-CMs derived from the symptomatic patient is due to impaired trafficking and increased degradation of the mutant KCNQ1 and wild-type human ether-a-go-go-related gene. In the iPSC-CMs of the asymptomatic (AS) patient, the activity of an E3 ubiquitin-protein ligase (Nedd4L) involved in channel protein degradation was reduced and resulted in a decreased arrhythmogenic substrate. Two single-nucleotide variants (SNVs) on the Myotubularin-related protein 4 (MTMR4) gene, an interactor of Nedd4L, were identified by whole-exome sequencing as potential contributors to decreased Nedd4L activity. Correction of these SNVs by CRISPR/Cas9 unmasked the LQTS phenotype in AS cells. Importantly, the same MTMR4 variants were present in 77% of AS Y111C mutation carriers of a separate cohort. Thus, genetically mediated interference with Nedd4L activation seems associated with protective effects. Our finding represents the first demonstration of the cellular mechanism of action of a protective modifier gene in LQTS. It provides new clues for advanced risk stratification and paves the way for the design of new therapies targeting this specific molecular pathway.

Identifiants

pubmed: 32173736
pii: 5804882
doi: 10.1093/cvr/cvaa019
pmc: PMC7898949
doi:

Substances chimiques

KCNQ1 Potassium Channel 0
KCNQ1 protein, human 0
Nedd4 Ubiquitin Protein Ligases EC 2.3.2.26
Nedd4L protein, human EC 2.3.2.26
MTMR4 protein, human EC 3.1.3.48
Protein Tyrosine Phosphatases, Non-Receptor EC 3.1.3.48

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

767-779

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Eur Heart J. 2013 Oct;34(40):3109-16
pubmed: 23509228
Int J Cardiol. 2017 Aug 1;240:367-371
pubmed: 28433559
Heart Rhythm. 2011 Apr;8(4):541-7
pubmed: 21129503
Eur Heart J. 2018 Nov 21;39(44):3925-3931
pubmed: 30215713
Hum Mol Genet. 2013 Apr 1;22(7):1395-403
pubmed: 23300193
Cardiovasc Res. 2007 Apr 1;74(1):64-74
pubmed: 17289006
J Am Coll Cardiol. 2013 Jul 16;62(3):169-180
pubmed: 23684683
PLoS One. 2012;7(7):e40288
pubmed: 22815737
Nat Protoc. 2013 Jan;8(1):162-75
pubmed: 23257984
Cell Reprogram. 2010 Dec;12(6):641-53
pubmed: 20858051
Gene. 2015 Feb 25;557(2):113-22
pubmed: 25527121
Trends Biochem Sci. 2018 Aug;43(8):635-647
pubmed: 30056838
Circ Genom Precis Med. 2018 Jan;11(1):e000043
pubmed: 29874173
J Am Coll Cardiol. 2012 Sep 11;60(11):1001-4
pubmed: 22749307
Circ Cardiovasc Genet. 2009 Dec;2(6):558-64
pubmed: 20031635
Cardiovasc Res. 2005 Aug 15;67(3):476-86
pubmed: 15935335
Hum Mol Genet. 2003 Oct 15;12 Spec No 2:R285-92
pubmed: 12925573
Circulation. 2001 Jan 2;103(1):89-95
pubmed: 11136691
J Clin Invest. 2018 Mar 01;128(3):1043-1056
pubmed: 29431731
J Biol Chem. 1998 Mar 20;273(12):6837-43
pubmed: 9506986
J Biol Chem. 2013 Dec 27;288(52):36841-54
pubmed: 24214981
Circulation. 2009 Nov 3;120(18):1761-7
pubmed: 19841298
Int J Cardiol. 2017 Jun 15;237:49-52
pubmed: 28408106
Cardiovasc Res. 2017 Apr 1;113(5):531-541
pubmed: 28158429
Biochem J. 2009 Apr 1;419(1):57-63
pubmed: 19125695
Eur Heart J. 2018 Apr 21;39(16):1446-1455
pubmed: 29020304
Arrhythm Electrophysiol Rev. 2019 Mar;8(2):105-110
pubmed: 31114684
J Physiol. 2000 Feb 15;523 Pt 1:67-81
pubmed: 10675203
Circ Res. 2008 Dec 5;103(12):1451-7
pubmed: 19008479
Channels (Austin). 2011 Jan-Feb;5(1):79-88
pubmed: 21057195
Circ Res. 2006 Nov 10;99(10):1076-83
pubmed: 17053194
Front Physiol. 2015 Feb 03;6:7
pubmed: 25691870
J Mol Cell Cardiol. 2011 Jul;51(1):90-8
pubmed: 21463633
J Biol Chem. 2009 Feb 20;284(8):5250-6
pubmed: 19114714
Circ Res. 2019 Aug 30;125(6):653-658
pubmed: 31465267
Eur Heart J. 2019 Jun 14;40(23):1832-1836
pubmed: 30753398

Auteurs

Yee-Ki Lee (YK)

Cardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Hong Kong-Guangdong Joint Laboratory on Stem Cell and Regenerative Medicine, The University of Hong Kong, Hong Kong SAR, China.

Luca Sala (L)

Department of Biotechnologies and Biosciences, University of Milano-Bicocca, Milano, Italy.
Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy.

Manuela Mura (M)

Laboratory of Experimental Cardiology for Cell and Molecular Therapy, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Department of Cardiothoracic and Vascular Sciences, Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Marcella Rocchetti (M)

Department of Biotechnologies and Biosciences, University of Milano-Bicocca, Milano, Italy.

Matteo Pedrazzini (M)

Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy.

Xinru Ran (X)

Cardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Hong Kong-Guangdong Joint Laboratory on Stem Cell and Regenerative Medicine, The University of Hong Kong, Hong Kong SAR, China.
Guangzhou Institutes of Biomedicine and Health, Guangzhou, China.

Timothy S H Mak (TSH)

Department of Psychiatry, The University of Hong Kong, Hong Kong SAR, China.

Lia Crotti (L)

Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy.
Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano, IRCCS, San Luca Hospital, Milan, Italy.
Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.

Pak C Sham (PC)

Department of Psychiatry, The University of Hong Kong, Hong Kong SAR, China.
Centre for Genomic Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
State Key Laboratory for Cognitive and Brain Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Eleonora Torre (E)

Department of Biotechnologies and Biosciences, University of Milano-Bicocca, Milano, Italy.

Antonio Zaza (A)

Department of Biotechnologies and Biosciences, University of Milano-Bicocca, Milano, Italy.

Peter J Schwartz (PJ)

Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin and Laboratory of Cardiovascular Genetics, Milan, Italy.

Hung-Fat Tse (HF)

Cardiology Division, Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Hong Kong-Guangdong Joint Laboratory on Stem Cell and Regenerative Medicine, The University of Hong Kong, Hong Kong SAR, China.
Guangzhou Institutes of Biomedicine and Health, Guangzhou, China.
Shenzhen Institutes of Research and Innovation, The University of Hong Kong, Hong Kong SAR, China.

Massimiliano Gnecchi (M)

Laboratory of Experimental Cardiology for Cell and Molecular Therapy, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Department of Cardiothoracic and Vascular Sciences, Coronary Care Unit and Laboratory of Clinical and Experimental Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Department of Molecular Medicine, Unit of Cardiology, University of Pavia, Pavia, Italy.
Department of Medicine, University of Cape Town, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH